Phase II Clinical Development of New Drugs

Discover the essential guide to Phase II clinical development with Phase II Clinical Development of New Drugs by Naitee Ting. Published by Springer Verlag in 2018, this comprehensive paperback edition spans 241 pages, offering invaluable insights for professionals in the pharmaceutical industry.

This book expertly outlines the critical strategies for planning and developing a Phase II program. It delves into the intricacies of designing Phase II clinical trials, ensuring that readers understand how to analyze data effectively. Whether you are a researcher, clinician, or industry professional, this resource equips you with the knowledge needed to navigate the complexities of drug development.

Enhance your understanding of clinical trial methodologies and data analysis with this authoritative text. Perfect for both seasoned professionals and newcomers alike, Phase II Clinical Development of New Drugs is a must-have addition to your library.